Glucotrack Inc. (GCTK)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Glucotrack Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RS Richard Slavik Newbridge Financial Services Group Inc. | 34 | $204 | $13.26 | -$190.74 | -93.5% |
Glucotrack Inc. (GCTK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Glucotrack Inc. ever had a stock split?
Glucotrack Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Paul V. Goode CEO | NASDAQ (CM) Exchange | 45824Q804 CUSIP |
| IL Country | 11 Employees | - Last Dividend | 13 Aug 2021 Last Split | 25 Apr 2013 IPO Date |
Overview
GlucoTrack, Inc. is a pioneering medical device company, initially established as Integrity Applications, Inc., before rebranding in November 2021. Founded in 2001 and headquartered in Or Yehuda, Israel, this company dedicates its efforts to addressing the needs of people with diabetes across the United States through innovative glucose monitoring solutions. GlucoTrack, Inc. has carved a niche in the development, design, and commercialization of non-invasive glucose monitoring devices, offering a significant advancement in diabetes care by eliminating the need for painful blood samples.
Products and Services
- GlucoTrack
At the forefront of GlucoTrack, Inc.'s product lineup is the GlucoTrack device, a hallmark in non-invasive blood glucose monitoring technology. Designed to cater to the daily needs of people with diabetes and pre-diabetics, GlucoTrack enables users to monitor their blood glucose levels without the conventional, painful methods of drawing blood. This product embodies the company's commitment to enhancing the quality of life for individuals managing diabetes by facilitating an easier, pain-free approach to glucose monitoring.
